Fundraising Fox
/Companies
Sign in

Valencia Technologies

Valencia, US · Founded 2014 · Delaware corporation · 1 known investors

Find your way into Valencia Technologies

163 people in our graph share verified history with the Valencia Technologies team — schools, employers, funds. One of them is your warm intro.

Kevin Morningstarunlockedknows Jim Surek · together at ALLOTROPE MEDICAL INC. (overlapped)
×2knows the team · via Explorer, a GHX company
knows the team · via Osprey Medical
knows the team · via ALLOTROPE MEDICAL INC.
×2knows the team · via Rhaeos
knows the team · via Advanced Bionics

Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.

HardwareHealthtechMedical Devices

Founders & leadership

Valencia Technologies was founded in 2014 by Jeff Greiner.

JGJeff Greiner
Jeff GreinerFounder & Board Member
SG
Stacy Greiner ChamblissExecutive
JSJim Surek
Jim SurekCEO and Board MemberJim Surek has spent over 30 years in medical device and digital health, holding CEO and commercial leadership roles at multiple companies including Advanced Bionics, where he grew the neuromodulation business to $198M in revenue, and Entellus Medical, which achieved 63% market share in in-office ENT procedures before going public in 2015. He is currently CEO of Valencia Technologies, which manufactures the FDA-approved eCoin tibial nerve implant for urinary incontinence.
SO
Stacy O'Connell GreinerCorporate Secretary

Board

KG
Kim GreinerBoard director

Investors · 1

Funding

SEC filings, press & company announcements

$54.1M disclosed across 9 rounds · 2013–2025

▶$1.9MraisedMar 2020 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GreinerExecutive Officer, Director
  • Stacy ChamblissExecutive Officer
  • David K.L. PetersonDirector
  • James CrinesDirector
Offering amount
$2M
Amount sold
$1.9M
Minimum investment
$50K
First sale
Dec 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2020 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GreinerExecutive Officer, Director
  • Stacy ChamblissExecutive Officer
  • James CrinesDirector
  • David K.L. PetersonDirector
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$20K
First sale
Aug 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MraisedMar 2020 · 12 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey GreinerExecutive Officer, Director
  • Stacy ChamblissExecutive Officer
  • David K.L. PetersonDirector
  • James CrinesDirector
  • Eve KurtinDirector
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$50K
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedMar 2020 · 28 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David PetersonDirector
  • James CrinesDirector
  • Jeffrey GreinerExecutive Officer, Director
  • Stacy ChamblissExecutive Officer
Offering amount
$4.2M
Amount sold
$4.2M
Minimum investment
$15K
Proceeds to insiders
$4.2M
First sale
Nov 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedMar 2020 · 36 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • James CrinesDirector
  • Stacy ChamblissExecutive Officer
  • Jeffrey GreinerExecutive Officer, Director
  • David K.L. PetersonDirector
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$5K
Proceeds to insiders
$1.5M
First sale
Jan 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedMar 2017 · 23 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David K.L. PetersonDirector
  • James CrinesDirector
  • Stacy ChamblissExecutive Officer
  • Jeff GreinerExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.9M
Minimum investment
$25K
First sale
Dec 2016
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedMar 2015 · 18 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Reginal D KingPromoter
  • Kautzman TamiPromoter
  • Kim GreinerDirector
  • Jeffrey Houston GreinerExecutive Officer, Director
  • Stacy Greiner ChamblissExecutive Officer
Offering amount
$30M
Amount sold
$2.2M
Minimum investment
$25K
Finders' fees
$1.2M
Proceeds to insiders
$1.2M
Placement agents
Morpheus Securities LLC, Independent Investment Bankers, Corp
First sale
Nov 2014
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$2.7MraisedJan 2014 · 15 investors · Other Health Care
Rule 506(c)
Officers, directors & promoters on the filing
  • Stacy O'Connell GreinerExecutive Officer
  • Kim Elizabeth GreinerDirector
  • Jeffrey Houston GreinerExecutive Officer, Director
Offering amount
$4M
Amount sold
$2.7M
Minimum investment
$50K
First sale
Oct 2013
Incorporated
Corporation, California, 2011
Federal exemptions
05, 06c, 4a5
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap
Boston Scientific15 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies competing with Valencia Technologies for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Boston Scientific to Acquire Valencia Technologies, Expanding Bladder Dysfunction Portfoliodigitalhealthnews.com · Jan 2026Valencia Technologies Receives Strategic Investment of up to $35M Appoints James D. Surek as CEOfinsmes.com · Feb 2025Trysignalbasetrysignalbase.com · Feb 2025Valencia Technologies raises $35M for coin-sized neuromod device, picks new CEOmassdevice.com · Feb 2025

Frequently asked questions

What does Valencia Technologies do?
Valencia Technologies is a neuromodulation company that makes eCoin, an FDA-approved coin-sized tibial nerve implant for treating Urge Urinary Incontinence. The leadless neurostimulator is placed under the skin near the ankle in a minimally invasive procedure to provide drug-free bladder control therapy for patients.
Who founded Valencia Technologies?
Valencia Technologies was founded by Jeff Greiner in 2014.
Who are Valencia Technologies's investors?
Valencia Technologies's investors include Inspire Global Ventures.
How much funding has Valencia Technologies raised?
Valencia Technologies has disclosed $54.1M raised across 9 rounds.
Where is Valencia Technologies headquartered?
Valencia Technologies is headquartered in Valencia, US.